This page shows Vicapsys Life Sc (VICP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Vicapsys Life Sc passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Vicapsys Life Sc generates $0.35 in operating cash flow (-$418K OCF vs -$1.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Vicapsys Life Sc earns $-203.1 in operating income for every $1 of interest expense (-$1.0M vs $5K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Vicapsys Life Sc reported -$1.2M in net income in fiscal year 2023. This represents a decrease of 20.0% from the prior year.
Vicapsys Life Sc earned $-0.03 per diluted share (EPS) in fiscal year 2023. This represents an increase of 0.0% from the prior year.
Vicapsys Life Sc held $9K in cash against $0 in long-term debt as of fiscal year 2023.
Vicapsys Life Sc had 32M shares outstanding in fiscal year 2023. This represents an increase of 0.5% from the prior year.
Vicapsys Life Sc invested $15K in research and development in fiscal year 2023. This represents an increase of 16.6% from the prior year.
VICP Income Statement
| Metric | Q3'24 | Q3'24 | Q3'24 | Q3'23 | Q3'23 | Q3'23 | Q3'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $4K-62.5% | $10K+2807.0% | $344 | N/A | $3K+63.3% | $2K-80.0% | $10K | N/A |
| SG&A Expenses | $4K+44.9% | $3K-91.9% | $35K | N/A | $27K+75.8% | $15K+306.9% | $4K | N/A |
| Operating Income | -$199K-9.4% | -$182K+11.0% | -$204K | N/A | -$175K-29.3% | -$136K+35.8% | -$211K | N/A |
| Interest Expense | $37K+344.2% | $8K+122.6% | -$37K | N/A | $10K | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$236K-23.9% | -$190K+41.9% | -$327K | N/A | -$240K-77.1% | -$136K+35.8% | -$211K | N/A |
| EPS (Diluted) | $-0.010.0% | $-0.010.0% | $-0.01 | N/A | $-0.01 | $0.00+100.0% | $-0.01 | N/A |
VICP Balance Sheet
| Metric | Q3'24 | Q3'24 | Q3'24 | Q3'23 | Q3'23 | Q3'23 | Q3'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $90K | N/A | N/A | $40K-81.0% | $208K-44.9% | $378K+497.5% | $63K-12.1% | $72K |
| Current Assets | $90K | N/A | N/A | $40K-81.0% | $208K-44.9% | $378K+497.5% | $63K-12.1% | $72K |
| Cash & Equivalents | $90K | N/A | N/A | $9K-82.4% | $54K-76.9% | $231K+5486.4% | $4K-70.6% | $14K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.7M | N/A | N/A | $2.0M+27.6% | $1.5M+4.8% | $1.5M+22.2% | $1.2M+17.8% | $1.0M |
| Current Liabilities | $2.7M+11.8% | $2.4M+8.4% | $2.3M+14.6% | $2.0M+27.6% | $1.5M+4.8% | $1.5M+22.2% | $1.2M+17.8% | $1.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$2.6M-8.2% | -$2.4M-8.4% | -$2.3M-17.0% | -$1.9M-44.6% | -$1.3M-22.0% | -$1.1M+4.2% | -$1.1M-20.0% | -$951K |
| Retained Earnings | -$17.1M-1.4% | -$16.8M-1.1% | -$16.6M-2.0% | -$16.3M-3.8% | -$15.7M-1.6% | -$15.5M-0.9% | -$15.3M-1.4% | -$15.1M |
VICP Cash Flow Statement
| Metric | Q3'24 | Q3'24 | Q3'24 | Q3'23 | Q3'23 | Q3'23 | Q3'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$40K-755.7% | $6K+165.4% | -$9K+88.5% | -$82K+23.6% | -$107K+50.8% | -$218K-2090.4% | -$10K-444.8% | $3K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $130K | N/A | N/A | $38K+153.9% | -$70K | N/A | N/A | -$15K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
VICP Financial Ratios
| Metric | Q3'24 | Q3'24 | Q3'24 | Q3'23 | Q3'23 | Q3'23 | Q3'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -262.9% | N/A | N/A | N/A | -115.3%-79.4pp | -35.9%+297.9pp | -333.8% | N/A |
| Current Ratio | 0.03 | N/A | N/A | 0.02-0.1 | 0.14-0.1 | 0.26+0.2 | 0.05-0.0 | 0.07 |
| Debt-to-Equity | -1.03 | N/A | N/A | -1.02+0.1 | -1.16+0.2 | -1.35-0.3 | -1.06+0.0 | -1.08 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$1.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.02), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Vicapsys Life Sc profitable?
No, Vicapsys Life Sc (VICP) reported a net income of -$1.2M in fiscal year 2023.
What is Vicapsys Life Sc's earnings per share (EPS)?
Vicapsys Life Sc (VICP) reported diluted earnings per share of $-0.03 for fiscal year 2023. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Vicapsys Life Sc's operating cash flow?
Vicapsys Life Sc (VICP) generated -$418K in operating cash flow during fiscal year 2023, representing cash generated from core business activities.
What are Vicapsys Life Sc's total assets?
Vicapsys Life Sc (VICP) had $40K in total assets as of fiscal year 2023, including both current and long-term assets.
How much does Vicapsys Life Sc spend on research and development?
Vicapsys Life Sc (VICP) invested $15K in research and development during fiscal year 2023.
How many shares does Vicapsys Life Sc have outstanding?
Vicapsys Life Sc (VICP) had 32M shares outstanding as of fiscal year 2023.
What is Vicapsys Life Sc's current ratio?
Vicapsys Life Sc (VICP) had a current ratio of 0.02 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is Vicapsys Life Sc's debt-to-equity ratio?
Vicapsys Life Sc (VICP) had a debt-to-equity ratio of -1.02 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Vicapsys Life Sc's return on assets (ROA)?
Vicapsys Life Sc (VICP) had a return on assets of -2980.9% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.
What is Vicapsys Life Sc's cash runway?
Based on fiscal year 2023 data, Vicapsys Life Sc (VICP) had $9K in cash against an annual operating cash burn of $418K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Vicapsys Life Sc's debt-to-equity ratio negative or unusual?
Vicapsys Life Sc (VICP) has negative shareholder equity of -$1.9M as of fiscal year 2023, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Vicapsys Life Sc's Piotroski F-Score?
Vicapsys Life Sc (VICP) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Vicapsys Life Sc's earnings high quality?
Vicapsys Life Sc (VICP) has an earnings quality ratio of 0.35x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Vicapsys Life Sc cover its interest payments?
Vicapsys Life Sc (VICP) has an interest coverage ratio of -203.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.